KAYLIE HUMPHREYS: Open Payments
NPI 1528676426 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 24 payments from 12 companies in 2025. Trend: 2023 $2,185 · 2024 $1,832 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $103 |
| PFIZER INC. | 5 | $98 |
| ABBVIE INC. | 4 | $92 |
| Lilly USA, LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $29 |
| Astellas Pharma US Inc | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: VRAYLAR, KRYSTEXXA, ELIQUIS, NURTEC ODT, MOUNJARO, Ozempic, Veozah, OTEZLA.
Industry payments across NV — which companies pay providers there.
